Association between serum magnesium levels and abdominal aorta calcification in patients with pre-dialysis chronic kidney disease stage 5.
<h4>Background</h4>Several studies have revealed the relationship between serum magnesium levels and vascular calcification in chronic kidney disease patients. Despite excellent predictability of abdominal aorta calcification for cardiovascular disease events, the relationship between se...
Guardado en:
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/84c379b7e0654a20b5513e9d7e0998eb |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:84c379b7e0654a20b5513e9d7e0998eb |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:84c379b7e0654a20b5513e9d7e0998eb2021-12-02T20:10:20ZAssociation between serum magnesium levels and abdominal aorta calcification in patients with pre-dialysis chronic kidney disease stage 5.1932-620310.1371/journal.pone.0253592https://doaj.org/article/84c379b7e0654a20b5513e9d7e0998eb2021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0253592https://doaj.org/toc/1932-6203<h4>Background</h4>Several studies have revealed the relationship between serum magnesium levels and vascular calcification in chronic kidney disease patients. Despite excellent predictability of abdominal aorta calcification for cardiovascular disease events, the relationship between serum magnesium levels and abdominal aorta calcification, as evaluated by quantitative methods, in pre-dialysis patients remains unclear. This study aimed to determine the abdominal aorta calcification volume using computerized tomography and its association with serum magnesium levels in pre-dialysis chronic kidney disease stage 5 patients.<h4>Methods</h4>This single-center cross-sectional study included 100 consecutive patients with pre-dialysis chronic kidney disease stage 5 between January 2016 and May 2020 at Aichi Medical University Hospital, Japan. The relationships between serum magnesium levels and the abdominal aorta calcification volume were assessed using multiple linear regression models after adjusting for clinically relevant factors. We also assessed clinical factors that affect serum magnesium levels.<h4>Results</h4>The mean serum magnesium level was 2.0 mg/dL (interquartile range, 1.8 to 2.3). Multivariate analyses revealed that a higher serum magnesium level (stand. β = -0.245, p = 0.010) was significantly associated with a reduced abdominal aorta calcification volume, and that a history of cardiovascular disease (stand. β = 0.3792, p < 0.001) and older age (stand. β = 0.278, p = 0.007) were significantly associated with an increased abdominal aorta calcification volume. Moreover, multivariate analysis showed that the use of proton pump inhibitor or potassium-competitive acid blocker was significantly associated with lower serum magnesium levels (stand. β = -0.246, p = 0.019).<h4>Conclusions</h4>The present study revealed that the higher Mg level was significantly associated with lower volume of abdominal aorta calcification in pre-dialysis chronic kidney disease stage 5 patients. Further studies should be undertaken to determine the appropriate magnesium level to suppress vascular calcification.Mayumi ItoMakoto YamaguchiTakayuki KatsunoHironobu NobataShiho IwagaitsuHirokazu SugiyamaHiroshi KinashiShogo BannoMasahiko AndoYoko KuboTakuji IshimotoYasuhiko ItoPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 6, p e0253592 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Mayumi Ito Makoto Yamaguchi Takayuki Katsuno Hironobu Nobata Shiho Iwagaitsu Hirokazu Sugiyama Hiroshi Kinashi Shogo Banno Masahiko Ando Yoko Kubo Takuji Ishimoto Yasuhiko Ito Association between serum magnesium levels and abdominal aorta calcification in patients with pre-dialysis chronic kidney disease stage 5. |
| description |
<h4>Background</h4>Several studies have revealed the relationship between serum magnesium levels and vascular calcification in chronic kidney disease patients. Despite excellent predictability of abdominal aorta calcification for cardiovascular disease events, the relationship between serum magnesium levels and abdominal aorta calcification, as evaluated by quantitative methods, in pre-dialysis patients remains unclear. This study aimed to determine the abdominal aorta calcification volume using computerized tomography and its association with serum magnesium levels in pre-dialysis chronic kidney disease stage 5 patients.<h4>Methods</h4>This single-center cross-sectional study included 100 consecutive patients with pre-dialysis chronic kidney disease stage 5 between January 2016 and May 2020 at Aichi Medical University Hospital, Japan. The relationships between serum magnesium levels and the abdominal aorta calcification volume were assessed using multiple linear regression models after adjusting for clinically relevant factors. We also assessed clinical factors that affect serum magnesium levels.<h4>Results</h4>The mean serum magnesium level was 2.0 mg/dL (interquartile range, 1.8 to 2.3). Multivariate analyses revealed that a higher serum magnesium level (stand. β = -0.245, p = 0.010) was significantly associated with a reduced abdominal aorta calcification volume, and that a history of cardiovascular disease (stand. β = 0.3792, p < 0.001) and older age (stand. β = 0.278, p = 0.007) were significantly associated with an increased abdominal aorta calcification volume. Moreover, multivariate analysis showed that the use of proton pump inhibitor or potassium-competitive acid blocker was significantly associated with lower serum magnesium levels (stand. β = -0.246, p = 0.019).<h4>Conclusions</h4>The present study revealed that the higher Mg level was significantly associated with lower volume of abdominal aorta calcification in pre-dialysis chronic kidney disease stage 5 patients. Further studies should be undertaken to determine the appropriate magnesium level to suppress vascular calcification. |
| format |
article |
| author |
Mayumi Ito Makoto Yamaguchi Takayuki Katsuno Hironobu Nobata Shiho Iwagaitsu Hirokazu Sugiyama Hiroshi Kinashi Shogo Banno Masahiko Ando Yoko Kubo Takuji Ishimoto Yasuhiko Ito |
| author_facet |
Mayumi Ito Makoto Yamaguchi Takayuki Katsuno Hironobu Nobata Shiho Iwagaitsu Hirokazu Sugiyama Hiroshi Kinashi Shogo Banno Masahiko Ando Yoko Kubo Takuji Ishimoto Yasuhiko Ito |
| author_sort |
Mayumi Ito |
| title |
Association between serum magnesium levels and abdominal aorta calcification in patients with pre-dialysis chronic kidney disease stage 5. |
| title_short |
Association between serum magnesium levels and abdominal aorta calcification in patients with pre-dialysis chronic kidney disease stage 5. |
| title_full |
Association between serum magnesium levels and abdominal aorta calcification in patients with pre-dialysis chronic kidney disease stage 5. |
| title_fullStr |
Association between serum magnesium levels and abdominal aorta calcification in patients with pre-dialysis chronic kidney disease stage 5. |
| title_full_unstemmed |
Association between serum magnesium levels and abdominal aorta calcification in patients with pre-dialysis chronic kidney disease stage 5. |
| title_sort |
association between serum magnesium levels and abdominal aorta calcification in patients with pre-dialysis chronic kidney disease stage 5. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2021 |
| url |
https://doaj.org/article/84c379b7e0654a20b5513e9d7e0998eb |
| work_keys_str_mv |
AT mayumiito associationbetweenserummagnesiumlevelsandabdominalaortacalcificationinpatientswithpredialysischronickidneydiseasestage5 AT makotoyamaguchi associationbetweenserummagnesiumlevelsandabdominalaortacalcificationinpatientswithpredialysischronickidneydiseasestage5 AT takayukikatsuno associationbetweenserummagnesiumlevelsandabdominalaortacalcificationinpatientswithpredialysischronickidneydiseasestage5 AT hironobunobata associationbetweenserummagnesiumlevelsandabdominalaortacalcificationinpatientswithpredialysischronickidneydiseasestage5 AT shihoiwagaitsu associationbetweenserummagnesiumlevelsandabdominalaortacalcificationinpatientswithpredialysischronickidneydiseasestage5 AT hirokazusugiyama associationbetweenserummagnesiumlevelsandabdominalaortacalcificationinpatientswithpredialysischronickidneydiseasestage5 AT hiroshikinashi associationbetweenserummagnesiumlevelsandabdominalaortacalcificationinpatientswithpredialysischronickidneydiseasestage5 AT shogobanno associationbetweenserummagnesiumlevelsandabdominalaortacalcificationinpatientswithpredialysischronickidneydiseasestage5 AT masahikoando associationbetweenserummagnesiumlevelsandabdominalaortacalcificationinpatientswithpredialysischronickidneydiseasestage5 AT yokokubo associationbetweenserummagnesiumlevelsandabdominalaortacalcificationinpatientswithpredialysischronickidneydiseasestage5 AT takujiishimoto associationbetweenserummagnesiumlevelsandabdominalaortacalcificationinpatientswithpredialysischronickidneydiseasestage5 AT yasuhikoito associationbetweenserummagnesiumlevelsandabdominalaortacalcificationinpatientswithpredialysischronickidneydiseasestage5 |
| _version_ |
1718375010461024256 |